CapsoVision (CV) Total Liabilities (2024 - 2026)
CapsoVision (CV) posted Total Liabilities of $4.9 million for Q4 2025, down 6.04% sequentially from $5.2 million in Q3 2025, and up 82.44% YoY from $2.7 million in Q4 2024.
CapsoVision (CV) Total Liabilities (2024 - 2026) Analysis & Trends
CapsoVision has reported Total Liabilities for 2 years, with the latest figure at $4.9 million in Q4 2025.
- Quarterly Total Liabilities rose 82.44% year-over-year to $4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (up 82.44% YoY) and the FY2025 annual result came in at $4.9 million, up 82.44% from the prior year.
- Total Liabilities declined to $4.9 million in Q4 2025 per CV's latest filing, from $5.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $5.2 million in Q3 2025 and troughed at $2.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.59 Bn | 193.99 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.90 Bn | 123.42 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.28 Bn | 109.06 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.95 Bn | 72.41 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.64 Bn | 31.53 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.08 Bn | 22.76 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | CapsoVision | 294.63 Mn | 285.55 Mn | 1.87 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.40 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Dec 31, 2024 | 2.69 Mn |